Everything you need to know as a first-time student.
Information and support for postgraduate study.
Courses, supervisors and your life as a researcher.
Discover our campuses, courses and entry requirements.
Step-by-step application guides for our courses.
Get financial support for your studies. Find a scholarship that's right for you.
Options like part-time, external and online study can help you tailor how you learn.
Our executive education courses give you the skills you need to lead in a fast-paced world.
Boost your career or extend your skills with a short course or unit.
Our free online courses are open to everyone.
Our internationally recognised research is supported by state-of-the-art research infrastructure.
Considering research with us? Here's what to expect.
Browse our experts or find a supervisor.
PhDs, research masters and professional doctorates.
Apply for scholarships for research study, or competitive grants as a professional researcher.
Our researchers work in supportive and established networks.
We value and promote integrity and ethical responsibility in all research we conduct.
Our strengths and areas of focus in research.
A selection of world-class research from our research centres and groups.
We collaborate with industry partners to research solutions for real-world problems, and to give our students hands-on experience in the workplace.
Work with our students and graduates, sponsor scholarships, prizes or events, or become an industry partner.
We offer commercial research and consultancy services, research commercialisation, and workplace training and development.
We're working with a range of industry partners and collaborators.
Our customised executive education equips your employees with tools and inspiration to give your organisation a real edge.
We offer short courses to help you advance your career and expand your skills.
Boeing Australia have collaborated on projects with us and provided sponsorship, and their staff have taught in our avionics program.
We are a highly successful and globally positioned Australian university with an applied emphasis in courses and research.
Make a real impact by giving to QUT and supporting our students, researchers and community.
Our history, key statistics, sustainability initiatives and programs and Indigenous acknowledgement.
Meet our staff and executive team.
Our awards, accreditation details, research rankings and scholarly achievements.
Our plans for expanding our university's achievements in learning, teaching and research.
Policies, procedures and annual reports.
What's on at QUT.
Want to work with us? See available jobs.
Our campuses and facilities, including maps, research locations and public venues.
Email: firstname.lastname@example.org Phone: +61 7 3138 2000
Our graduates run successful businesses, conduct ground-breaking research and make significant contributions to their communities.
We celebrate our alumni with annual awards for graduates and students.
Get involved with QUT by engaging with and supporting our current students.
Once you've graduated, we encourage you to keep in touch with the QUT community and your fellow alumni.
Email: email@example.com Phone: +61 7 3138 4778 Mon-Fri, 8.30am-5pm
Award-winning singer-songwriter and ARIA-nominated artist Kate Miller-Heidke is the 2016 QUT Alumnus of the Year.
Step-by-step guide to applying as an international student.
We offer scholarships for international students to help with study and living costs.
You may be able to meet with a QUT staff member or official representative in your city.
Find out more about living and studying in Brisbane.
While you're studying here, you can access a range of support services to help you adjust to life in Brisbane.
Come to QUT for one or two semesters.
Freecall: 1800 181 848 (within Australia)
Phone: +61 3 9627 4853 (outside Australia)
Subscribe for email updates
QUT researchers in collaboration with Health Focus Products Australia (HFPA) have discovered a group of naturally occurring compounds in an Australian native plant that effectively kill the Zika virus.
Email: firstname.lastname@example.org Phone: +61 7 3138 2361
You are here:
A new personalised treatment for the debilitating arthritic condition ankylosing spondylitis and other auto-immune diseases will be developed through a research collaboration led by QUT’s Professor of Genomics, Matt Brown under an agreement between Janssen Biotech Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, and QUT.
The announcement was made at a ceremony marking the official opening of the Johnson & Johnson Innovation Partnering Office @ QUT in the presence of Queensland Premier Annastacia Palaszczuk. It was the first agreement facilitated by the new Partnering Office at QUT’s Kelvin Grove campus.
“Ankylosing spondylitis, Crohn’s disease, ulcerative colitis, and psoriasis all share in common some major genetic risk factors,” Professor Brown said. “The collaboration with Janssen Biotech will enable development of new therapies for these conditions, rapidly accelerating our research taking genetic findings back into the clinic leading to better health for our patients.”“The agreement with QUT is part of Johnson & Johnson Innovations' strong commitment to collaborating in cutting edge early-stage innovation wherever it happens and to pursuing new treatment options for people in need in the areas of consumer health, medical devices, and pharmaceuticals, including difficult-to-treat autoimmune diseases such as ankylosing spondylitis,” said Kathy Connell, Director of New Ventures Australia and New Zealand (ANZ), for Johnson & Johnson Innovation, which is affiliated with Janssen ANZ (Janssen-Cilag Pty Ltd).“This first agreement made through our newly launched Johnson & Johnson Innovation Partnering Office @ QUT represents the importance of collaboration across academia, industry, and government to further build the Queensland life sciences ecosystem and improve access to medical innovation in this important region – and beyond,” she added.Professor Brown, from QUT’s Institute of Health and Biomedical Innovation and based at Brisbane’s Translational Research Institute, is an internationally renowned genetics researcher who has led global efforts to identify genes causing the common form of arthritis, ankylosing spondylitis.His research has identified key genetic pathways involved in the diseases ankylosing spondylitis, Crohn’s disease, ulcerative colitis, and psoriasis that affect three per cent of the world population, opening pathways to new treatments.“As a clinician who works in research, my dream has always been to develop new and better treatments for patients with the conditions I manage and research,” Professor Brown said. “This partnership with Janssen will greatly increase our chances of successfully taking our genetics research findings back into the clinic, leading to better health for our patients.”
Media contact: QUT Niki Widdowson 07 3138 2999 or Rose Trapnell 07 3138 2361 or 0407 585 901 email@example.com
Professor Matt Brown is collaborating with Janssen Biotech to develop new therapies to provide more personalised treatments for suffers of Crohn's and other diseases that share common genetic risk factors.